olivLaw · US equity research
CorVel Corporation CRVL
Insurance Agents, Brokers & Service · SIC 6411 · Vertical: Insurance Agents, Brokers & Service (SIC 6411)
CorVel is an independent provider of medical cost containment and managed care services for workers' compensation, auto insurance claims and group health, serving insurers, third-party administrators and self-insured employers. Revenue for the quarter ended June 30 2026 rose to 259.9 million USD, up 11% from the prior year, which keeps its operating trend in focus now.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, CorVel Corporation (CRVL) stock was 87.38 USD (+5.74% on the day), with market capitalisation 4.4 bn USD, P/E 38.9 on diluted EPS of 2.25 USD over the last 12 months, beta 0.53, 52-week range 46.00–87.38 USD. Latest reported quarter (Q1 2027): revenue of 259.9 m USD (+10.7% YoY), net income of 32.2 m USD (+18.3% YoY), diluted EPS 0.63 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 75.8
- overbought (≥ 70)
- Bollinger (20, 2)
- 76.10 – 86.56
- above the upper band · %B 1.08 · band width 12.9%
- SMA 50 / 200
- 75.54 / 62.71
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 2.60 / 2.58
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +15.0% | −1.1% | +16.1 pp | — |
| 3 months | +39.7% | −0.5% | +40.1 pp | — |
| 6 months | +57.8% | +4.4% | +53.4 pp | — |
| Year to date | +29.1% | +12.3% | +16.8 pp | — |
| 1 year | +14.9% | +13.5% | +1.3 pp | −3.9% |
| 3 years | +31.3% | +76.4% | −45.1 pp | +1.3% |
| 5 years | +38.3% | +63.7% | −25.4 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q1 2027 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 224.4 m | 228.0 m | 231.5 m | 234.7 m | 239.6 m | 235.6 m | 248.5 m | 259.9 m |
| Cost of revenue | 173.6 m | 175.1 m | 173.3 m | 178.0 m | 181.5 m | 180.7 m | 185.5 m | 192.1 m |
| Gross profit | 50.7 m | 52.9 m | 58.2 m | 56.8 m | 58.2 m | 54.9 m | 63.0 m | 67.8 m |
| Depreciation & amortisation | 7.7 m | 7.5 m | 7.6 m | 7.6 m | 7.8 m | 8.1 m | 8.3 m | 8.8 m |
| Pre-tax income | 28.7 m | 30.8 m | 33.3 m | 35.3 m | 35.9 m | 32.2 m | 39.7 m | 43.3 m |
| Income tax | 5.3 m | 7.0 m | 6.9 m | 8.0 m | 8.0 m | 8.1 m | 8.7 m | 11.1 m |
| Net income | 23.4 m | 23.8 m | 26.4 m | 27.2 m | 27.9 m | 24.2 m | 31.0 m | 32.2 m |
| Diluted EPS | 0.45 | 0.46 | 0.51 ≈ | 0.52 | 0.54 | 0.47 | 0.61 ≈ | 0.63 |
| Operating cash flow | 22.3 m ≈ | 41.6 m ≈ | 22.9 m | 55.0 m | 25.0 m ≈ | 46.1 m ≈ | 29.5 m | 49.9 m |
| Capex | 9.9 m ≈ | 9.5 m ≈ | 8.7 m | 15.5 m | 9.8 m ≈ | 11.0 m ≈ | 9.2 m | 6.8 m |
| Share repurchases | 9.6 m ≈ | 9.5 m ≈ | 9.0 m | 9.6 m | 12.8 m ≈ | 13.6 m ≈ | 20.2 m | 22.0 m |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 90 percentile of its own 39-quarter history (min 7.2, median 13.4, max 60.9; quarters with earnings only).
Fiscal years
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 595.7 m | 592.2 m | 552.6 m | 646.2 m | 718.6 m | 795.3 m | 895.6 m | 958.5 m |
| Revenue YoY | +6.7% | −0.6% | −6.7% | +16.9% | +11.2% | +10.7% | +12.6% | +7.0% |
| Net income | 46.7 m | 47.4 m | 46.4 m | 66.4 m | 66.4 m | 76.3 m | 95.2 m | 110.3 m |
| Net income YoY | +30.8% | +1.4% | −2.2% | +43.3% | −0.1% | +14.9% | +24.8% | +16.0% |
| Diluted EPS | 2.46 | 2.55 | 2.55 | 3.66 | 1.26 | 1.47 | 1.83 | 2.14 |
| Diluted EPS YoY | +31.6% | +3.7% | 0.0% | +43.5% | −65.6% | +16.7% | +24.5% | +16.9% |
| net % | 7.8% | 8.0% | 8.4% | 10.3% | 9.2% | 9.6% | 10.6% | 11.5% |
| Free cash flow | 63.4 m | 48.5 m | 77.1 m | 37.4 m | 56.0 m | 70.0 m | 91.6 m | 110.3 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2026 · 31 Mar 2026
- Cash
- 233.1 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- 394.2 m USD
- Total assets
- 643.0 m USD
- Debt / equity
- unavailable
- Current ratio
- 2.03x
- ROE
- 30.8%
- ROA
- 18.6%
- FCF margin
- 11.5%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 552.6 m | 646.2 m | 718.6 m | 795.3 m | 895.6 m | 958.5 m | SEC (XBRL)· 22 May 2026verified |
| Cost of revenue | 429.0 m | 494.1 m | 560.3 m | 623.6 m | 685.9 m | 725.7 m | SEC (XBRL)· 22 May 2026verified |
| Gross profit | 123.6 m | 152.1 m | 158.3 m | 171.7 m | 209.7 m | 232.9 m | SEC (XBRL)· 22 May 2026verified |
| Depreciation & amortisation | 23.4 m | 23.9 m | 25.1 m | 26.3 m | 29.5 m | 31.8 m | SEC (XBRL)· 22 May 2026verified |
| Pre-tax income | 59.2 m | 84.5 m | 84.6 m | 95.1 m | 120.8 m | 143.1 m | SEC (XBRL)· 22 May 2026verified |
| Income tax | 12.8 m | 18.1 m | 18.2 m | 18.8 m | 25.7 m | 32.8 m | SEC (XBRL)· 22 May 2026verified |
| Net income | 46.4 m | 66.4 m | 66.4 m | 76.3 m | 95.2 m | 110.3 m | SEC (XBRL)· 22 May 2026verified |
| Diluted EPS | 2.55 | 3.66 | 1.26 | 1.47 | 1.83 | 2.14 | SEC (XBRL)· 22 May 2026verified |
| Weighted average diluted shares | 18.2 m | 18.1 m | 52.8 m | 52.0 m | 52.0 m | 51.6 m | SEC (XBRL)· 22 May 2026verified |
Balance sheet · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 139.7 m | 97.5 m | 71.3 m | 105.6 m | 170.6 m | 233.1 m | SEC (XBRL)· 22 May 2026verified |
| Receivables | 64.7 m | 82.6 m | 81.0 m | 97.1 m | 104.1 m | 101.3 m | SEC (XBRL)· 22 May 2026verified |
| Current assets | 268.9 m | 265.0 m | 243.8 m | 302.2 m | 386.7 m | 462.3 m | SEC (XBRL)· 22 May 2026verified |
| Property, plant & equipment, net | 70.6 m | 76.3 m | 82.8 m | 85.9 m | 92.1 m | 117.9 m | SEC (XBRL)· 22 May 2026verified |
| Goodwill | 36.8 m | 36.8 m | 36.8 m | 36.8 m | 36.8 m | 36.8 m | SEC (XBRL)· 22 May 2026verified |
| Intangibles (excl. goodwill) | 2.1 m | 1.7 m | 1.2 m | 821.0 k | 438.0 k | 263.0 k | SEC (XBRL)· 22 May 2026verified |
| Total assets | 424.8 m | 415.2 m | 393.9 m | 454.7 m | 546.0 m | 643.0 m | SEC (XBRL)· 22 May 2026verified |
| Accounts payable | 12.4 m | 14.1 m | 15.1 m | 16.4 m | 15.4 m | 24.3 m | SEC (XBRL)· 22 May 2026verified |
| Current liabilities | 162.5 m | 171.4 m | 167.9 m | 184.5 m | 204.0 m | 228.1 m | SEC (XBRL)· 22 May 2026verified |
| Total liabilities | 204.4 m | 202.9 m | 191.7 m | 207.0 m | 224.0 m | 248.8 m | SEC (XBRL)· 22 May 2026verified |
| Equity | 220.4 m † | 212.4 m † | 202.2 m † | 247.6 m † | 322.0 m † | 394.2 m † | SEC (XBRL)· 22 May 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 94.4 m | 67.2 m | 82.3 m | 99.2 m | 127.3 m | 155.6 m | SEC (XBRL)· 22 May 2026verified |
| Capex | 17.2 m | 29.8 m | 26.3 m | 29.2 m | 35.8 m | 45.4 m | SEC (XBRL)· 22 May 2026verified |
| Free cash flow | 77.1 m ≈ | 37.4 m ≈ | 56.0 m ≈ | 70.0 m ≈ | 91.6 m ≈ | 110.3 m ≈ | SEC (XBRL)· 22 May 2026derived |
| Investing cash flow | -17.2 m | -29.8 m | -26.3 m | -29.2 m | -35.8 m | -45.4 m | SEC (XBRL)· 22 May 2026verified |
| Financing cash flow | -20.6 m | -79.6 m | -82.1 m | -35.8 m | -26.5 m | -47.8 m | SEC (XBRL)· 22 May 2026verified |
| Share repurchases | 32.7 m | 90.1 m | 93.7 m | 45.7 m | 37.6 m | 56.2 m | SEC (XBRL)· 22 May 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 58.3% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 4.4 bn USD
Key indicators
Coverage and freshness
Score by group
58% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 33.17 – 90.76 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/E33.17 – 90.76 (Mid 49.56)11 companies used · median multiple 22.1x · quartiles 14.8x – 40.4xACT, AJG, AON, BRO, GSHD, MRSH, RYAN, SLQT, TWFG, WDH, WTW
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 58.3% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 11.7% | 66 (vs peers) | 11% |
| FCF conversion · Quality | 98.7% | 98 (on a fixed band) | 11% |
| Revenue CAGR 3Y · Growth | 10.1% | 84 (on a fixed band) | 14% |
| EPS CAGR 3Y · Growth | 19.3% | 100 (on a fixed band) | 14% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 1.9x | 95 (on a fixed band) | 7% |
| P/E (TTM) · Valuation | 38.9x | 38 (vs peers) | 18% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 2.6% | 32 (on a fixed band) | 14% |
| Shareholder yield (distributions) · Returns | 1.6% | 22 (on a fixed band) | 11% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial95/100 · 1/3 factors with a value
- Growth92/100 · 2/2 factors with a value
- Quality82/100 · 2/3 factors with a value
- Returns· partial22/100 · 1/2 factors with a value
- Valuation36/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
CORVEL CORPORATION (CRVL). Latest full fiscal year: 2026; data up to 2026-06-30.
Figures computed from the financial statements: revenue 958.5 m USD in 2026; YoY growth 7.0%; net margin 11.7%; ROE 30.7%.
The estimated value range is 33.17–90.76 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 49.56 USD, the price of 87.38 USD leaves a potential of -43.3% (value / price − 1) and a margin of safety of -76.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 58.3% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- FCF conversion: 98.7%
- Revenue CAGR 3Y: 10.1%
- EPS CAGR 3Y: 19.3%
- Current ratio: 1.9x
What contradicts it
- Shareholder yield (distributions): 1.6%
Not assessed (insufficient data or a ratio without meaning): ROIC, Net debt / EBITDA, Interest coverage, EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Insurance Agents, Brokers & Service (SIC 6411) · same industry (4-digit SIC) · compared with 29 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| MRSHMarsh & Mclennan Companies, Inc. | 100.0 bn | 25.2 | 26.7% | 14.2% | +10.3% | +15% / +5% |
| XHGXChange TEC.INC | 85.9 bn | — | — | -204.9% | +24.9% | +253% / −100% |
| AJGArthur J. Gallagher & Co. | 73.9 bn | 47.1 | 6.7% | 10.0% | +20.7% | +16% / +16% |
| AONAon plc | 73.1 bn | 18.9 | 43.6% | 22.2% | +9.4% | −3% / +5% |
| WTWWillis Towers Watson PLC | 31.1 bn | 20.5 | 20.2% | 15.2% | −2.2% | +5% / +37% |
| BROBrown & Brown, Inc. | 24.5 bn | 22.1 | 9.7% | 17.6% | +22.8% | −8% / −1% |
| EQHEquitable Holdings, Inc. | 15.3 bn | — | -508.8% | -8.7% | −6.1% | +20% / +83% |
| AIFUAIFU Inc. | 10.5 bn | — | -155.9% | -408.8% | −67.9% | −84% / −100% |
| ACTEnact Holdings, Inc. | 6.6 bn | 10.7 | 12.7% | 53.8% | +2.8% | +25% / +74% |
| HGTYHagerty, Inc. | 6.5 bn | 108.0 | 25.6% | 4.4% | +17.3% | +40% / +121% |
| RYANRyan Specialty Holdings, Inc. | 5.2 bn | 49.9 | 19.4% | 3.2% | +21.3% | −18% / +4% |
| CRVLCorvel Corporation | 4.4 bn | 38.9 | 30.7% | 11.7% | +7.0% | +15% / +31% |
| WDHWaterdrop Inc. | 3.6 bn | 50.5 | 11.6% | 14.2% | +49.8% | −44% / −16% |
| ARXAccelerant Holdings | 3.3 bn | — | -241.6% | -112.1% | +51.5% | +36% / unavailable |
| NPNeptune Insurance Holdings Inc. | 2.7 bn | 91.6 | — | 22.7% | +33.7% | +22% / unavailable |
| GSHDGoosehead Insurance, Inc. | 1.2 bn | 33.8 | — | 8.8% | +16.2% | −21% / −23% |
| HUIZHuize Holding Limited | 1.1 bn | — | 1.0% | 0.3% | +32.2% | −31% / −48% |
| BWINThe Baldwin Insurance Group, Inc. | 1.1 bn | — | -10.7% | -4.7% | +8.3% | +13% / +84% |
| RDZNRoadzen Inc. | 92.8 m | — | — | -46.9% | +24.2% | −37% / −78% |
| SLQTSelectQuote, Inc. | 88.1 m | 7.3 | 23.4% | 4.6% | +6.0% | −66% / −61% |
| EHTHeHealth, Inc | 20.3 m | — | 5.0% | 5.4% | +4.1% | −84% / −91% |
| EZRAReliance Global Group, Inc. | 2.4 m | — | -123.4% | -54.3% | −11.6% | −91% / −100% |
| YBYuanbao Inc. | — | — | 152.7% | 29.9% | +33.1% | −43% / unavailable |
| CCGCheche Group Inc. | — | — | -5.0% | -0.6% | −13.3% | +751% / +6% |
| HITHealth In Tech, Inc. | — | — | -21.9% | -12.0% | +71.0% | −61% / unavailable |
1- and 3-year price returns: for CRVL from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 55.47 Total return -37% · Per year -37% | 97.82 Total return 12% · Per year 12% | 147.00 Total return 68% · Per year 68% |
| 3 years | 60.04 Total return -31% · Per year -12% | 118.53 Total return 36% · Per year 11% | 194.68 Total return 123% · Per year 31% |
| 5 years | 64.99 Total return -26% · Per year -6% | 143.64 Total return 64% · Per year 10% | 257.82 Total return 195% · Per year 24% |
- Exit P/E± 29.63
- Net margin± 20.74
- Annual revenue growth± 16.16
- Annual dilution± 1.74
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (03 Nov 2026 · results).
In brief
CorVel is an independent provider of medical cost containment and managed care services for workers' compensation, auto insurance claims and group health, serving insurers, third-party administrators and self-insured employers. Revenue for the quarter ended June 30 2026 rose to 259.9 million USD, up 11% from the prior year 2, which keeps its operating trend in focus now.
SWOT
Strengths
- A proprietary technology platform with an extensive rules engine and a national PPO network supports service efficiency 1.
- The financial position is solid, with growing revenue and no borrowings at the end of the latest quarter 3.
- The integrated offering linking patient management and network services lets clients rely on a single partner 1.
Weaknesses
- The company depends on workplace injury volumes and on payors outsourcing work, so declines can hit revenue directly 1.
- The patient management segment has had declining performance in some years, with local competition and staff turnover 1.
- The company has faced integration challenges with acquired businesses, which remains a risk for inorganic growth 1.
Opportunities
Risks
- Dependence on workplace injury volumeshigh
A continued decline in occupational injuries or workers' compensation costs could weaken revenue over the long term 1.
- Reduced outsourcing by clientsmedium
If payors bring services in-house, the volume of the company's activity could fall 1.
- Intensified competitionmedium
Larger competitors with greater resources could reduce market share or pressure pricing 1.
- Labour and benefit costsmedium
Wage inflation and employee benefit costs could compress margins if they cannot be passed on to clients 1.
- Change in leadershiplow
The move to a new chief executive in July 2026 could affect strategy and operational continuity 2.
Investment thesis
What would need to be true (bull case)
What to watch
- Trend in revenue and gross margin in coming quartersQ2 2027
- Effect of the leadership change on strategy2027
- Pace of share repurchases and use of cashnext 10-K
- Development of occupational injury counts reported by the Bureau of Labor Statistics2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (03 Nov 2026 · results).
The business
CorVel provides medical management and cost containment services for workers' compensation, auto claims and group health, applying artificial intelligence, machine learning and natural language processing 1. Services are delivered as fully integrated end-to-end programs, standalone modules or targeted add-ons, depending on the client 1. The company was incorporated in Delaware in 1987 and is headquartered in Fort Worth, Texas 1.
Segments
Patient management services
This segment covers claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation and disability management, as well as liability and auto claims management 12. Services are sold on a standalone basis or as part of an integrated cost containment model 1.
Network solutions services
The network solutions segment aims to reduce prices paid for medical services through bill review, a proprietary PPO network, pharmacy services, directed care (CareIQ), Medicare solutions and clearinghouse services 2. The CERIS payment integrity offering is part of this portfolio 3.
Market context
Trends
- Rising market sharetailwind
Management says the decline in claims has been offset by higher market share, which could support revenue growth if the trend holds 12.
- Fewer workplace injuriesheadwind
Work-related injuries have declined over the long term as labour becomes less intensive and employers prevent injuries more actively, which could reduce demand for the company's services 1.
- Shift to early interventionheadwind
Greater use of early intervention services by payors could reduce revenue from later-stage network and case management services 1.
- Technology and artificial intelligencemixed
The AI-based rules engine and new technology integration can support efficiency and margins, but failure to develop competitive products could weaken the company's position 12.
Competitive position
The market is fragmented, with national managed care providers, preferred provider networks, smaller independent vendors and insurers that may perform services in-house 1. Many larger competitors have greater financial and marketing resources than CorVel 1.
- National workers' compensation managed care providers
Primary competitors operating nationally in workers' compensation managed care 1.
- Smaller local unbundled service vendors
Local firms, often tied to relationships with regional insurance adjusters 1.
- Insurance carriers performing services in-house
Large carriers that may bring managed care functions in-house, reducing outsourced volume 1.
- Third-party administrators and PPO networks
Competitors in network and claims administration, including healthcare managed care companies 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report03 Nov 2026Results of operations · Financial statements and exhibits
- Current report11 Aug 2026Shareholder vote
- Quarterly report06 Aug 2026
- Current report05 Aug 2026Results of operations · Financial statements and exhibits
- Proxy statement26 Jun 2026
- Current report01 Jun 2026Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
- Annual report22 May 2026
- Current report20 May 2026Results of operations · Financial statements and exhibits
- Quarterly report05 Feb 2026
- Current report03 Feb 2026Results of operations · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2026-03-31 · SEC / CorVel Corporation · 22 May 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / CorVel Corporation · 06 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / CorVel Corporation · 05 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.